CLINICAL_TRIALS
trial_result
· 2025-08-26
Clinical Trial Update: Phase 1 Study of SAR440894 vs Placebo [Phase 1]
Summary
The Phase 1 trial of SAR440894 versus placebo in chikungunya virus infection has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Chikungunya Virus Infection | Phase 1 | Status: COMPLETED | Results posted: 2025-08-26